Seres Therapeutics, Inc. (MCRB) Income Statement 2013 - 2025

Seres Therapeutics, Inc.

NasdaqGS:MCRB

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 115.62 M

Share Price

USD 13.24

Avg Daily Volume

114,618

Change (1 day)

-8.88%

Change (1 year)

-49.85%

Change (YTD)

-20.34%

Seres Therapeutics, Inc. Income Statement 2015 - 2025

This table shows the Income Statement for Seres Therapeutics, Inc. going from 2015 until 2025. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.